Health Policy

Change and growth in our health care system are driven not only by federal and state regulations and legislation but also by private sector entrepreneurs who strive to expand choice, identify new treatments, and develop cures. 

Our Mission

The U.S. Chamber of Commerce's Health Policy Division identifies and advances legislative and regulatory policies to - 

  • Increase access to coverage and services

Scope of Issues

Through the Chamber's ability to convene dynamic groups of stakeholders and engage with our diverse member companies, we drive the dialogue and lead strategic partnerships to accomplish the following: 

 

Advocacy

The Chamber educates and advises member companies about key developments in Washington and collaborates with leaders in Congress and federal agencies to further our policy priorities. 

 

Policy Committees and Working Groups

The Health Policy Division represents our members' views by crafting policy positions through the Employee Benefits Committee (EBC), the Health Care Regulatory Task Force, the Supporting Opioid Solutions (SOS) Task Force, the Health Insurer Council, and the Health Policy Advisory Board. 

 

Recent Activity

EventOct 31, 2019 - 9:00am to 6:00pm
The Business of Health event key graphic

The Business of Health: Transforming with Transparency

During this half-day event we'll examine the dynamics of health care and the people, ideas, and innovations that are leading the way.

Letters to CongressOct 15, 2019 - 2:15pm

U.S. Chamber Letter Opposing H.R. 3, the “Lower Drug Costs Now Act of 2019”

This Hill letter was sent to the U.S. House of Representatives, opposing H.R. 3, the “Lower Drug Costs Now Act of 2019.”

Issue BriefJul 30, 2019 - 11:45am

Association Health Plans: Everything You Need to Know

Download the Association Health Plan Issue Brief to learn everything you need to know about AHPs.

Letters to CongressJul 24, 2019 - 12:45pm

U.S. Chamber Letter on S.64, "Preserve Access to Affordable Generics and Biosimilars Act"

This letter was sent to the Senate Committee on the Judiciary, on S. 64, the "Preserve Access to Affordable Generics and Biosimilars Act."

ReportJul 19, 2019 - 12:45pm

National Healthcare Claims Database: Voter Poll

This poll, in partnership with Morning Consult, found that creating a national healthcare claims database, or All Payer Claims Database (APCD), raises concerns among Americans over the privacy of their personal healthcare information.

Letters to CongressJul 17, 2019 - 9:30am

Coalition Letter on H.R. 748, "Middle Class Health Benefits Tax Repeal Act of 2019"

This Coalition letter was sent to the U.S. House of Representatives, supporting H.R. 748, the "Middle Class Health Benefits Tax Repeal Act of 2019."

Letters to CongressJul 16, 2019 - 2:30pm

U.S. Chamber Key Vote Alert! on H.R. 748, "Middle Class Health Benefits Tax Repeal Act of 2019"

This Key Vote Alert! letter was sent to the U.S. House of Representatives, supporting H.R. 748, the “Middle Class Health Benefits Tax Repeal Act of 2019.”

Letters to CongressJul 15, 2019 - 4:45pm

U.S. Chamber Letter on Drug Price Controls

This Hill letter was sent to the Senate Committee on Finance on potential government price controls on drugs, therapies, and other medical products.